Effect of vaccination on nasopharyngeal pneumococcus serotype
Phase 1
- Conditions
- Pneumonia due to Streptococcus pneumoniae.Pneumonia (acute) (double) (migratory) (purulent) (septic) (unresolved) - in (due to) - Streptococcus - pneumoniae
- Registration Number
- IRCT2012080510497N1
- Lead Sponsor
- Vice Chancellor for Research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 58
Inclusion Criteria
All children with age of 6 months to 5 years referred to pediatric clinics of Rasoul Akram Hospital after filling the consent letter by their patents.
Exclusion criteria: Previous disease including diabetes, spina bifida, asplenia, sickle cell anemia, innate or acquired immune system deficiency, previous cochlear implantation, chronic cardiac and pulmonary disease.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Colonization of organism. Timepoint: On month before and one year after injection of Prevnar vaccine. Method of measurement: Culture.
- Secondary Outcome Measures
Name Time Method